Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
This Special Issue highlights the most recent research on depression, anxiety and dementia, with attention to comorbidity in a range of diseases. The symptoms of depression, anxiety and dementia are the most common comorbid manifestations present in patients suffering from neurodegenerative and psyc...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (266 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04324nam-a2201141z--4500 | ||
|---|---|---|---|
| 001 | 993545286104498 | ||
| 005 | 20231214133038.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202207s2022 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5690000000011939 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/87528 | ||
| 035 | |a (EXLCZ)995690000000011939 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Tanaka, Masaru |4 edt | |
| 245 | 1 | 0 | |a Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry |
| 246 | |a Crosstalk between Depression, Anxiety, and Dementia | ||
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (266 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a This Special Issue highlights the most recent research on depression, anxiety and dementia, with attention to comorbidity in a range of diseases. The symptoms of depression, anxiety and dementia are the most common comorbid manifestations present in patients suffering from neurodegenerative and psychiatric diseases. Together, these illnesses constitute an extremely complex and challenging research field due to their inherent multifactorial causative factors, heterogeneous pathogenesis, and mental and behavioral manifestations. This Special Issue covers laboratory, clinical and statistical studies on the crosstalk between depression, anxiety, dementia, Alzheimer’s disease, multiple sclerosis, schizophrenia, diabetes mellitus, Down’s syndrome, and/or compulsive disorders. It contains contributions from 71 authors, has been reviewed by 25 referees, and edited by three academic editors and one managing editor. | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Clinical & internal medicine |2 bicssc | |
| 653 | |a dementia | ||
| 653 | |a behavioral and psychological symptoms of dementia | ||
| 653 | |a systematic review | ||
| 653 | |a meta-analysis | ||
| 653 | |a animal-assisted intervention | ||
| 653 | |a pet-robot intervention | ||
| 653 | |a G protein-coupled receptors | ||
| 653 | |a GPR120 | ||
| 653 | |a FFAR4 | ||
| 653 | |a schizophrenia | ||
| 653 | |a polyunsaturated fatty acids | ||
| 653 | |a long-chain fatty acids | ||
| 653 | |a omega-3 | ||
| 653 | |a nutritional psychiatry | ||
| 653 | |a Alzheimer’s disease | ||
| 653 | |a psychiatric disease | ||
| 653 | |a depression | ||
| 653 | |a anxiety | ||
| 653 | |a Down’s syndrome | ||
| 653 | |a inositol | ||
| 653 | |a nutraceutical | ||
| 653 | |a insulin signaling | ||
| 653 | |a antioxidant | ||
| 653 | |a aging | ||
| 653 | |a psilocybin | ||
| 653 | |a clinical trials | ||
| 653 | |a oxidative stress | ||
| 653 | |a redox | ||
| 653 | |a multiple sclerosis | ||
| 653 | |a biomarker | ||
| 653 | |a neurodegenerative disease | ||
| 653 | |a personalized medicine | ||
| 653 | |a major depressive disorder | ||
| 653 | |a longitudinal study | ||
| 653 | |a LC-MS/MS | ||
| 653 | |a plasma protein biomarker | ||
| 653 | |a drug response monitoring | ||
| 653 | |a multiple reaction monitoring | ||
| 653 | |a diabetes mellitus | ||
| 653 | |a type 2 | ||
| 653 | |a dyslipidemias | ||
| 653 | |a hypertension | ||
| 653 | |a post-stroke depression | ||
| 653 | |a disability level | ||
| 653 | |a mortality | ||
| 653 | |a late-life depression | ||
| 653 | |a neuroimaging | ||
| 653 | |a resting-state functional magnetic resonance imaging | ||
| 653 | |a default mode network | ||
| 653 | |a executive control network | ||
| 653 | |a salience network | ||
| 653 | |a healthy life expectancy (HALE) | ||
| 653 | |a morbidity/mortality paradox | ||
| 653 | |a cognition | ||
| 653 | |a systolic blood pressure | ||
| 653 | |a cerebral blood flow | ||
| 653 | |a arterial properties | ||
| 653 | |a angiogenesis | ||
| 653 | |a gender medicine | ||
| 653 | |a neurodegenerative disorders | ||
| 653 | |a kisspeptin | ||
| 653 | |a locomotion | ||
| 653 | |a Kiss1 receptor | ||
| 653 | |a HPA axis | ||
| 653 | |a HPG axis | ||
| 653 | |a nucleus accumbens | ||
| 653 | |a stroke | ||
| 653 | |a lipid | ||
| 653 | |a diabetes | ||
| 776 | |z 3-0365-4001-6 | ||
| 776 | |z 3-0365-4002-4 | ||
| 700 | 1 | |a Tanaka, Masaru |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:40:31 Europe/Vienna |f system |c marc21 |a 2022-07-14 08:50:39 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337848390004498&Force_direct=true |Z 5337848390004498 |b Available |8 5337848390004498 | ||